amikacin has been researched along with pefloxacin in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (47.06) | 18.7374 |
1990's | 10 (29.41) | 18.2507 |
2000's | 5 (14.71) | 29.6817 |
2010's | 3 (8.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Courvalin, P; Galimand, M; Périchon, B | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bush, V; Korshunov, VM; Romanchuk, LA | 1 |
Busch, W; Dugasheva, LG; Gorodinskaia, VS; Il'chenko, AA; Korshunov, VM; Radakova, ED; Romanchuk, LA; Zhukhovitskiĭ, VG | 1 |
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 2 |
Amrani, R; Beklahia, C; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
Chaste, A; Combremont, AG; David, C; Saison, C | 1 |
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 2 |
Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
Bayer, AS; Hirano, L; Yih, J | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
Boisivon, A; Guiomar, C; Gutmann, L | 1 |
Auzepy, P; Pezzano, M; Richard, C; Singlas, E; Sultan, E | 1 |
Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Auzepy, P; Richard, C; Singlas, E; Sultan, E | 1 |
Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ | 1 |
Anastassiadou, H; Dassiou, M; Samonis, G | 1 |
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G | 1 |
Majtán, V; Majtánová, L | 2 |
Alamowitch, B; Bethoux, JP; Bouillot, JL; Fourmestraux, J; Ghossain, M; Sellam, P; Thomas, F | 1 |
Mayer, I; Nagy, E | 2 |
Qin, X; Xiao, G; Xu, N; Yuan, J; Zheng, J | 1 |
Dekens, J; Fodzo, E; Popesco, D; Tchaoussoff, J; Yagoubi, A | 1 |
2 trial(s) available for amikacin and pefloxacin
Article | Year |
---|---|
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
32 other study(ies) available for amikacin and pefloxacin
Article | Year |
---|---|
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Selective decontamination of the intestine and total gnotobiologic isolation in treatment of mice with acute radiation sickness].
Topics: Acute Disease; Amikacin; Animals; Ciprofloxacin; Decontamination; Germ-Free Life; Intestines; Mice; Mice, Inbred CBA; Opportunistic Infections; Pefloxacin; Radiation Injuries, Experimental | 1992 |
[The experimental and clinical effect of ciprofloxacin on the microflora of the gastrointestinal tract].
Topics: Adult; Amikacin; Animals; Cimetidine; Ciprofloxacin; Digestive System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Germ-Free Life; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mice; Mice, Inbred CBA; Middle Aged; Pefloxacin; Time Factors | 1991 |
[Enzymologic aspect of piperacillin combinations].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Enterobacter; Enzyme Induction; Hydrolysis; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa | 1986 |
[In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
Topics: Amikacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Staphylococcal Infections; Staphylococcus aureus | 1988 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1988 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Interaction between piperacillin and pefloxacin or amikacin on the selection of resistant mutants of Pseudomonas aeruginosa.
Topics: Amikacin; beta-Lactamases; Drug Interactions; Microbial Sensitivity Tests; Mutation; Pefloxacin; Phenotype; Piperacillin; Pseudomonas aeruginosa; Selection, Genetic | 1988 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
Topics: Aged; Amikacin; Bacterial Infections; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Pefloxacin | 1988 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
Topics: Aged; Amikacin; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Norfloxacin; Pefloxacin; Resuscitation | 1987 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin | 1994 |
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam | 1997 |
Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Cell Wall; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Coloring Agents; Congo Red; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pefloxacin; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Virus Activation | 1997 |
Postantibiotic effect of some antibiotics on the metabolism of Pseudomonas aeruginosa.
Topics: Adenine; Amikacin; Anti-Bacterial Agents; Carbon Radioisotopes; Cell Division; Ciprofloxacin; Imipenem; Leucine; Meropenem; Nucleic Acid Synthesis Inhibitors; Oxygen Consumption; Pefloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Thienamycins | 1998 |
[Emphysematous cystitis: report of a case].
Topics: Amikacin; Amoxicillin; Anti-Infective Agents, Urinary; Cystitis; Emphysema; Follow-Up Studies; Humans; Male; Middle Aged; Pefloxacin; Penicillins; Tomography, X-Ray Computed; Ultrasonography; Urinary Retention | 1998 |
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas | 1999 |
[An experimental study on the release of endotoxin from gram negative bacteria induced by antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Gram-Negative Bacteria; Imipenem; Lipopolysaccharides; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pefloxacin; Pseudomonas aeruginosa | 2001 |
[Peridural abscess complicating spinal anesthesia in a diabetic patient].
Topics: 4-Quinolones; Abscess; Amikacin; Anesthesia, Spinal; Anti-Infective Agents; Diabetes Mellitus, Type 2; Disease Susceptibility; Drainage; Drug Therapy, Combination; Epidural Space; Fluoroquinolones; Humans; Laminectomy; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Oxacillin; Pefloxacin; Postoperative Complications; Povidone-Iodine; Punctures; Quinolones; Spinal Diseases; Staphylococcal Infections | 1997 |
Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
Topics: 4-Quinolones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Automation; Ceftazidime; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Netilmicin; Ofloxacin; Pefloxacin; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections | 2000 |